Multicenter study in southern South America of the in vitro activity of telithromycin in strains with defined resistance phenotypes isolated from community-acquired respiratory infections;Estudio multicéntrico en el Cono Sur Americano de la actividad comparativa in vitro de telitromicina en cepas con fenotipos definidos de resistencia asociadas a infecciones respiratorias adquiridas en la comunidad

Revista Espanola de Quimioterapia

Volumn 14, Issue 3, 2001, Pages 269-274

  Casellas, J M ^a   Visser, M ^a   Mac Dougall, N ^a   Coco, B ^a   Tome G ^a   Gliosca, L ^a  

^a Centro Estudios en Antimicrobianos   (Argentina)

Author keywords

In vitro activity; Respiratory infection

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; KETOLIDE; OXACILLIN; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DRUG HALF LIFE; DRUG MECHANISM; HAEMOPHILUS INFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MULTICENTER STUDY; PH; PHASE 3 CLINICAL TRIAL; PNEUMONIA; RESPIRATORY TRACT INFECTION; SOUTH AMERICA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; RESPIRATORY TRACT INFECTIONS; SOUTH AMERICA;

EID: 0035195560     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by 11 different ketolide antibiotics
2. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain 11 of 23S rRNA
3. Susceptibilities of penicillin and erythromycin-susceptible and resistant pneumococci to HMR-3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents
4. Distribution of erythromycin A resistance determinant in Spanish Streptococcus pneumoniae isolates and comparative activity of telithromycin
5. Actividad de macról idos sobre bacterias aisladas de infeccciones respiratorias adquiridas en la comunidad durante el periodo 1997-1999
6. Estudio multicéntrico argentino sobre la actividad comparativa in vitro de gatifloxacina frente a aislados recuperados de infecciones del tracto respiratorio adquiridas en la comunidad en adaltos
7. Macrolides, lincosamide and streptogramin resistance in viridans group streptococci
8. Erythromycin resistant Streptococcus pyogenes in a pediatric hospital in Buenos Aires
9. Invasive infections in patients older that 6 years in Argentina
10. Epidemiology of bacterial incidence and resistance in community acquired respiratory tract infections in South America
11. Prevalence of antimicrobial resistance among respiratory tract isolates in two medical centers in Argentina: 1997-1998 Results from the SENTRY Program
12. Pharmacokinetics of the new ketolide telithromycin (HMR-3647) administered in ascending single multiple doses
13. Differences in the in vivo pharmacodynamics of telithromycin and azithromycin against Streptococcus pneumoniae
14. Oral telithromycin 800 mg once daily for 5 days is well tolerated and as effective as oral chlarithromycin 250 mg twice daily for 10 days in group A-haemolytic streptococcal pharyngitis/tonsillitis
15. Efficacy and tolerability of a 5-day course of a new ketolide antimicrobial, telithromycin, for the treatment for acute sinusitis
16. Telithromycin
17. Efficacy of telithromycin, a new once-daily antimicrobial, in the treatment of the community acquired pneumonia
18. Resistance to erythromycin in group A streptococci
19. Lung concentrations of telithromycin after oral dosing